211 related articles for article (PubMed ID: 16978399)
1. Identification of genes associated with cisplatin resistance in human oral squamous cell carcinoma cell line.
Zhang P; Zhang Z; Zhou X; Qiu W; Chen F; Chen W
BMC Cancer; 2006 Sep; 6():224. PubMed ID: 16978399
[TBL] [Abstract][Full Text] [Related]
2. Establishment and gene analysis of a cisplatin-resistant cell line, Sa-3R, derived from oral squamous cell carcinoma.
Nakatani K; Nakamura M; Uzawa K; Wada T; Seki N; Tanzawa H; Fujita S
Oncol Rep; 2005 Apr; 13(4):709-14. PubMed ID: 15756446
[TBL] [Abstract][Full Text] [Related]
3. Identification of cisplatin-resistance related genes in head and neck squamous cell carcinoma.
Yamano Y; Uzawa K; Saito K; Nakashima D; Kasamatsu A; Koike H; Kouzu Y; Shinozuka K; Nakatani K; Negoro K; Fujita S; Tanzawa H
Int J Cancer; 2010 Jan; 126(2):437-49. PubMed ID: 19569180
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines.
Yu ZW; Zhong LP; Ji T; Zhang P; Chen WT; Zhang CP
Oral Oncol; 2010 Apr; 46(4):317-22. PubMed ID: 20219416
[TBL] [Abstract][Full Text] [Related]
5. [Establishment and drug-resistance gene expression of cisplatin-resistant cell line Tca8113/CDDP].
Zhou XJ; Li Q; Chen WT
Shanghai Kou Qiang Yi Xue; 2003 Dec; 12(6):432-5. PubMed ID: 14966583
[TBL] [Abstract][Full Text] [Related]
6. [In vitro gene silencing by siRNA of cyclin D1 on tongue squamous cell carcinoma cell line resistant to cisplatin].
Zhou XJ; Zhang ZY; Zhang P; Pan HY; Chen WT; Ye DX
Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 Nov; 41(11):646-9. PubMed ID: 17331354
[TBL] [Abstract][Full Text] [Related]
7. Silencing of GLUT-1 inhibits sensitization of oral cancer cells to cisplatin during hypoxia.
Shimanishi M; Ogi K; Sogabe Y; Kaneko T; Dehari H; Miyazaki A; Hiratsuka H
J Oral Pathol Med; 2013 May; 42(5):382-8. PubMed ID: 23227892
[TBL] [Abstract][Full Text] [Related]
8. Cloning and functional characterization of TCRP1, a novel gene mediating resistance to cisplatin in an oral squamous cell carcinoma cell line.
Gu Y; Fan S; Xiong Y; Peng B; Zheng G; Yu Y; Ouyang Y; He Z
FEBS Lett; 2011 Mar; 585(6):881-7. PubMed ID: 21334329
[TBL] [Abstract][Full Text] [Related]
9. Establishment and characterization of a cisplatin-resistant oral squamous cell carcinoma cell line, H-1R.
Nakamura M; Nakatani K; Uzawa K; Ono K; Uesugi H; Ogawara K; Shiiba M; Bukawa H; Yokoe H; Wada T; Fujita S; Tanzawa H
Oncol Rep; 2005 Nov; 14(5):1281-6. PubMed ID: 16211297
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of midkine induces cisplatin resistance in human oral squamous cell carcinoma.
Ota T; Jono H; Ota K; Shinriki S; Ueda M; Sueyoshi T; Nakatani K; Hiraishi Y; Wada T; Fujita S; Obayashi K; Shinohara M; Ando Y
Oncol Rep; 2012 May; 27(5):1674-80. PubMed ID: 22344722
[TBL] [Abstract][Full Text] [Related]
11. Bmi1 essentially mediates podocalyxin-enhanced Cisplatin chemoresistance in oral tongue squamous cell carcinoma.
Zhou Y; Zhang L; Pan H; Wang B; Yan F; Fang X; Munnee K; Tang Z
PLoS One; 2015; 10(4):e0123208. PubMed ID: 25915207
[TBL] [Abstract][Full Text] [Related]
12. Identification of carbonic anhydrase 9 as a contributor to pingyangmycin-induced drug resistance in human tongue cancer cells.
Zheng G; Zhou M; Ou X; Peng B; Yu Y; Kong F; Ouyang Y; He Z
FEBS J; 2010 Nov; 277(21):4506-18. PubMed ID: 21040473
[TBL] [Abstract][Full Text] [Related]
13. [Insight into the role of IGF2BP1 in drug resistant mechanism of oral squamous cell carcinoma].
Xie F; Qin X; Tong T; Jiang YY; Zhang JJ
Shanghai Kou Qiang Yi Xue; 2021 Oct; 30(5):456-461. PubMed ID: 34888594
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling of a clonal isolate of oxaliplatin-resistant ovarian carcinoma cell line A2780/C10.
Varma RR; Hector SM; Clark K; Greco WR; Hawthorn L; Pendyala L
Oncol Rep; 2005 Oct; 14(4):925-32. PubMed ID: 16142353
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of cyclin D1 expression by cyclin D1 shRNAs in human oral squamous cell carcinoma cells is associated with increased cisplatin chemosensitivity.
Zhou X; Zhang Z; Yang X; Chen W; Zhang P
Int J Cancer; 2009 Jan; 124(2):483-9. PubMed ID: 18942709
[TBL] [Abstract][Full Text] [Related]
16. Purification and biochemical characterization of a novel protein-tongue cancer chemotherapy resistance-associated protein1 (TCRP1).
Peng B; Yi S; Gu Y; Zheng G; He Z
Protein Expr Purif; 2012 Apr; 82(2):360-7. PubMed ID: 22365988
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of CD147 contributes to the chemoresistance of head and neck squamous cell carcinoma cells.
Huang Z; Wang L; Wang Y; Zhuo Y; Li H; Chen J; Chen W
J Oral Pathol Med; 2013 Aug; 42(7):541-6. PubMed ID: 23413783
[TBL] [Abstract][Full Text] [Related]
18. WP1066 sensitizes oral squamous cell carcinoma cells to cisplatin by targeting STAT3/miR-21 axis.
Zhou X; Ren Y; Liu A; Jin R; Jiang Q; Huang Y; Kong L; Wang X; Zhang L
Sci Rep; 2014 Dec; 4():7461. PubMed ID: 25514838
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cyclin D1 by shRNA is associated with enhanced sensitivity to conventional therapies for head and neck squamous cell carcinoma.
Kothari V; Mulherkar R
Anticancer Res; 2012 Jan; 32(1):121-8. PubMed ID: 22213296
[TBL] [Abstract][Full Text] [Related]
20. Transfection of truncated bone morphogenetic protein receptor-II into oral squamous cell carcinoma cell line Tca8113 and inhibitory effect on proliferation and inductive effect on apoptosis.
Fu S; Lv HB; Liu Y; Zhao Y; He LS; Jin Y
J Oral Pathol Med; 2011 Jul; 40(6):490-6. PubMed ID: 21496104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]